ストックスクリーナーアプリを入手
0.9839
0.71%
0.0069
アフターアワーズ：
.96
-0.0239
-2.43%
前日終値:
$0.977
開ける：
$0.972
24時間の取引高:
1.45M
Relative Volume:
2.05
時価総額：
$48.19M
収益：
-
当期純損益:
$-56.85M
株価収益率:
-0.6311
EPS:
-1.559
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-47.39%
1か月 パフォーマンス:
-35.27%
6か月 パフォーマンス:
-33.52%
1年 パフォーマンス:
-51.77%
1日の値動き範囲:
$0.95
$1.02
1週間の範囲:
$0.825
$1.05
52週間の値動き範囲:
$0.825
$3.72
Fractyl Health Inc Stock (GUTS) Company Profile
GUTS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GUTS
Fractyl Health Inc
|
0.9839 | 47.85M | 0 | -56.85M | 0 | -1.559 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.77 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.55 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.93 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
637.56 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.10 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Fractyl Health Inc Stock (GUTS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-02-28 | 開始されました | Evercore ISI | Outperform |
| 2024-02-27 | 開始されました | BofA Securities | Buy |
| 2024-02-27 | 開始されました | Morgan Stanley | Overweight |
Fractyl Health Inc (GUTS) 最新ニュース
Earnings call transcript: Fractyl Health Q2 2025 sees increased R&D, net loss - Investing.com
Fractyl Health Announces Second Quarter 2025 Financial Results and Business Updates - GlobeNewswire
Short Interest Drops in Fractyl Health Inc. After RallyBreakout Confirmation With Entry Tracker Enabled - beatles.ru
Bollinger Bands Expand on Fractyl Health Inc. — Volatility AheadShort Term Setup With Predictive Chart Confirmed - beatles.ru
Biotech Alert: Searches spiking for these stocks today - TipRanks
Fractyl Health shares rise 1.75% intraday after closing $23 million public offering. - AInvest
Fractyl Health announces proposed public offering - MSN
Fractyl Health raises $23 million in public offering with warrants By Investing.com - Investing.com Canada
Fractyl Health raises $23 million in public offering with warrants - Investing.com India
Fractyl Health Announces Closing of $23 Million - GlobeNewswire
Fractyl Health Raises $23M in Public Offering, Could Expand to $69M Through Warrants - Stock Titan
Fractyl Health to Report Second Quarter 2025 Financial Results and Provide Business Updates on August 12, 2025, and Will Participate in an Upcoming Investor Conference - The Manila Times
Fractyl Health to Report Second Quarter 2025 Financial - GlobeNewswire
Fractyl Health Earnings Preview: Metabolic Disease Innovator Updates Investors on August 12 - Stock Titan
Fractyl Health prices 19.05M shares at $1.05 in underwritten public offering - TipRanks
Fractyl Health's GUTS Plummets 47%: What's Fueling the Sudden Freefall? - AInvest
Fractyl Health stock plunges after $20 million public offering - Investing.com India
Fractyl Health stock plunges after $20 million public offering By Investing.com - Investing.com Australia
Fractyl Health (GUTS.O) Plummets 49%: Technical Signals, Order-Flow Clues, and Sector Divergence Point to Key Catalyst - AInvest
US Stocks Edge Higher; McDonald's Posts Upbeat Earnings - Benzinga
Fractyl Health prices $20 million public offering of common stock - Investing.com
Fractyl Health prices $20 million public offering of common stock By Investing.com - Investing.com Canada
Fractyl Health announces pricing of $20 million underwritten public offering - MarketScreener
Fractyl Health Announces Pricing of $20 Million Underwritten Public Offering - GlobeNewswire
Fractyl Health Secures $20M Funding to Advance Revolutionary Diabetes and Obesity Therapeutics - Stock Titan
Fractyl Health Stock Plunges 27.81% on Public Offering - AInvest
Fractyl Health plunges after launching stock offering - TradingView
Fractyl Health Drops 26% Pre-Market: What You Need to Know - Benzinga
Fractyl Health announces two-year follow-up data from Revita study - TipRanks
Fractyl Health announces common stock offering, no amount given - TipRanks
Fractyl Health announces proposed public offering of common stock By Investing.com - Investing.com Nigeria
Fractyl Health Reports Potent and Durable Two-Year Real-World Outcomes with Revita® Showing Sustained Weight Loss and Improved Glucose Control After a Single Procedure - The Manila Times
Fractyl Health announces proposed public offering of common stock - Investing.com
Fractyl Health Announces Proposed Public Offering - GlobeNewswire
Metabolic Disease Pioneer Fractyl Health Launches Major Public Offering with Innovative Warrant Structure - Stock Titan
Fractyl’s Revita procedure shows durable weight loss in diabetes patients - Investing.com
Fractyl Health Reports Potent and Durable Two-Year - GlobeNewswire
Breakthrough Diabetes Device Maintains 9.6% Weight Loss for 2 Years with Single TreatmentNew Real-World Data - Stock Titan
Can machine learning forecast Fractyl Health Inc. recoveryLow Risk Trade Timing with Analysis Metrics - Newser
Using economic indicators to assess Fractyl Health Inc. potentialFree Real-Time Analysis With Entry Targets - Newser
How Fractyl Health Inc. stock performs during market volatilityRisk/Reward Optimization Entry Point Analysis - Newser
Predicting Fractyl Health Inc. trend using moving averagesShort-Term Bounce Forecast for Oversold Stocks - Newser
Canaccord Genuity Reiterates Buy Rating on Fractyl Health (GUTS) - MSN
Published on: 2025-08-03 21:36:23 - Newser
Advanced analytics toolkit walkthrough for Fractyl Health Inc.Weekly Movement Forecast With Chart Signals - Newser
Is Fractyl Health Inc. stock overvalued or undervaluedBuild a portfolio that withstands market volatility - Jammu Links News
When is Fractyl Health Inc. stock expected to show significant growthBreakthrough stock performance - Jammu Links News
What are the latest earnings results for Fractyl Health Inc.Discover stocks with superior performance - Jammu Links News
What drives Fractyl Health Inc. stock priceCapital growth strategies that work - Jammu Links News
What earnings revisions data tells us about Fractyl Health Inc.Technical Reversal Pattern Summary and Tracker - Newser
What are analysts’ price targets for Fractyl Health Inc. in the next 12 monthsStay ahead with advanced stock screening tools - Jammu Links News
Fractyl Health Inc (GUTS) 財務データ
収益
当期純利益
現金流量
EPS
Fractyl Health Inc (GUTS) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Barnes Kelly Ann | Director |
Mar 14 '25 |
Buy |
1.30 |
31,000 |
40,210 |
31,000 |
| SCHULMAN AMY W | Director |
Mar 13 '25 |
Buy |
1.17 |
8,550 |
9,964 |
8,550 |
| BRADLEY WILLIAM | Director |
Mar 13 '25 |
Buy |
1.26 |
16,129 |
20,358 |
16,129 |
| Conaway Samuel | Director |
Mar 13 '25 |
Buy |
1.17 |
8,550 |
9,964 |
8,550 |
| Rajagopalan Harith | Chief Executive Officer |
Jan 31 '25 |
Option Exercise |
1.70 |
90,972 |
154,652 |
582,301 |
| Rajagopalan Harith | Chief Executive Officer |
Jan 30 '25 |
Option Exercise |
1.70 |
20,948 |
35,612 |
512,277 |
| Rajagopalan Harith | Chief Executive Officer |
Jan 31 '25 |
Sale |
1.82 |
90,972 |
165,205 |
491,329 |
| Rajagopalan Harith | Chief Executive Officer |
Jan 30 '25 |
Sale |
1.95 |
20,948 |
40,798 |
491,329 |
| Caplan Jay David | President, Chief Product Off. |
Jan 31 '25 |
Option Exercise |
1.70 |
22,346 |
37,988 |
175,890 |
| Caplan Jay David | President, Chief Product Off. |
Jan 30 '25 |
Option Exercise |
1.70 |
21,472 |
36,502 |
175,016 |
0.91%
3.06%
大文字化:
|
ボリューム (24 時間):